Xenia Beebe Searle

This inventor holds 20 USPTO granted patents and 8 published patent applications, plus 2 CIPO patents and 8 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Galapagos Nv, Abbvie S.a.r.l., Abbott Laboratories Corporation. Active years: 2005-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xenia Beebe Searle. Retrieved from https://idiyas.com/inventor/xenia-beebe-searle

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 20 (Patent Applications = 8)

% Patents Active = 80.0

CIPO Patents = 2 (Patent Applications = 9)

EPO Patents = 8 (Patent Applications = 9)

Average Co-Inventor Count = 8.6

ph-index = 6

Forward Citations = 122(Granted Patents)

Company Filing History:

Abbott Laboratories Corporation

where one patent can have more than one assignee

Years Active: 2005-2021

Loading Chart...

Areas of Expertise:

Cystic Fibrosis

Pyrrolidines

Tricyclics

Chromanes

Tetrahydropyrans

Calcium Channel Modulators

Calcium Channel Blockers

Antibacterial Compounds

Azabicyclic Compounds

CNS Active Agents

Hydrazide

Angiogenesis Inhibitors

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10988454 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use (2021-04-27),

2. 10981890 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use (2021-04-20),

3. 10844042 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use (2020-11-24),

4. 10844041 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use (2020-11-24),

5. 10829473 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use (2020-11-10),

6. 10428017 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use (2019-10-01),

7. 10399940 - Substituted pyrrolidines and methods of use (2019-09-03),

8. 10118916 - Modulators of cystic fibrosis transmembrane conductance regulator protein (2018-11-06),

9. 9981910 - Substituted pyrrolidines and methods of use (2018-05-29),

10. 9840513 - Substituted tricyclics and method of use (2017-12-12),

11. 9642831 - Substituted chromanes and method of use (2017-05-09),

12. 9567322 - Substituted tetrahydropyrans and method of use (2017-02-14),

13. 8796470 - Substituted octahydrocyclopenta[c]pyrroles as calcium channel modulators (2014-08-05),

14. 8691865 - Substituted octahydrocyclopenta[C]pyrrol-4-amines as calcium channel blockers (2014-04-08),

15. 8129417 - Substituted octahydrocyclopenta[C]pyrrol-4-amines as calcium channel blockers (2012-03-06),

Title: The Innovative Mind of Xenia Beebe Searle

Introduction: Xenia Beebe Searle, a pioneering inventor hailing from Grayslake, IL (US), is a remarkable individual known for his groundbreaking contributions to the world of inventions and patents.

Latest Patents: Xenia Beebe Searle has recently been granted several patents, including a cutting-edge technology for sustainable energy production and a revolutionary medical device aimed at improving patient care.

Career Highlights: Throughout his illustrious career, Xenia Beebe Searle has consistently pushed the boundaries of innovation, with a focus on creating solutions that address pressing global challenges. His work has garnered recognition for its creativity and impact.

Collaborations: Xenia Beebe Searle has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His ability to work across disciplines and industries has led to the development of truly transformative technologies.

Conclusion: In conclusion, Xenia Beebe Searle stands as a visionary inventor whose dedication to innovation has left an indelible mark on the world. His relentless pursuit of novel solutions continues to inspire future generations of inventors and innovators.

Profile summary based on public USPTO records.